We are live on ! Find out more
ODT

Odonate Therapeutics, Inc. Common Stock

Delisted

ODT was delisted on the 14th of January, 2022.

95 hedge funds and large institutions have $1.29B invested in Odonate Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 32 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

850% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 2

53% more capital invested

Capital invested by funds: $848M → $1.29B (+$446M)

22% more funds holding

Funds holding: 7895 (+17)

6% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 32

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

62% less call options, than puts

Call options by funds: $1.42M | Put options by funds: $3.72M

Holders
95
Holders Change
+17
Holders Change %
+21.79%
% of All Funds
1.95%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.08%
New
19
Increased
34
Reduced
32
Closed
2
Calls
$1.42M
Puts
$3.72M
Net Calls
-$2.3M
Net Calls Change
+$542K
Name Holding Trade Value Shares
Change
Change in
Stake
Jacobs Levy Equity Management
26
Jacobs Levy Equity Management
New Jersey
$2.28M +$927K +28,646 +113%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$2.28M +$197K +6,073 +13%
Assenagon Asset Management
28
Assenagon Asset Management
Luxembourg
$2.21M +$1.69M +52,200 New
Citadel Advisors
29
Citadel Advisors
Florida
$1.94M -$56K -1,730 -4%
SM
30
Sabby Management
Florida
$1.72M -$275K -8,488 -17%
MAM
31
Martingale Asset Management
Massachusetts
$1.5M +$1.14M +35,300 New
TD Asset Management
32
TD Asset Management
Ontario, Canada
$1.32M +$35.6K +1,100 +4%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$1.23M -$556K -17,185 -37%
Swiss National Bank
34
Swiss National Bank
Switzerland
$1.21M +$29.1K +900 +3%
Goldman Sachs
35
Goldman Sachs
New York
$1.16M +$535K +16,537 +151%
Bank of America
36
Bank of America
North Carolina
$1.14M +$4.27K +132 +0.5%
Two Sigma Advisers
37
Two Sigma Advisers
New York
$1.09M -$22.7K -700 -3%
Federated Hermes
38
Federated Hermes
Pennsylvania
$1.02M +$782K +24,175 New
BC
39
Birchview Capital
Vermont
$847K
Citigroup
40
Citigroup
New York
$841K +$552K +17,057 +610%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$835K +$165K +5,102 +35%
Wells Fargo
42
Wells Fargo
California
$825K +$180K +5,558 +40%
ZIM
43
Zacks Investment Management
Illinois
$789K +$603K +18,639 New
Bessemer Group
44
Bessemer Group
New Jersey
$766K +$586K +18,100 New
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$677K +$129K +3,975 +33%
State of Wisconsin Investment Board
46
State of Wisconsin Investment Board
Wisconsin
$673K -$87.4K -2,700 -15%
AllianceBernstein
47
AllianceBernstein
Tennessee
$639K -$16.2K -500 -3%
SO
48
STRS Ohio
Ohio
$605K -$155K -4,800 -25%
CIP
49
Chartwell Investment Partners
Pennsylvania
$541K -$151K -4,657 -27%
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$525K +$77.7K +2,400 +24%

ODT Hedge Fund Activity: Q2 2020 in Review

95 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Odonate Therapeutics, Inc. Common Stock (ODT) for Q2 2020, worth a combined $1.29B — up 53% from $848M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ODT positions and 2 closed out — a net gain of 17 holders — while 34 added to existing stakes and 32 trimmed.

The largest buyer was BlackRock, adding an estimated $4.37M. The largest seller was Carillon Tower Advisers, cutting an estimated $7.97M.

  • 95 institutional investors held Odonate Therapeutics, Inc. Common Stock (ODT) as of Q2 2020, up from 78 in Q1 2020.
  • Funds reported $1.29B of Odonate Therapeutics, Inc. Common Stock stock for Q2 2020, up 53% quarter-over-quarter.
  • 19 funds opened new Odonate Therapeutics, Inc. Common Stock positions in Q2 2020 and 2 closed out, a net change of +17 holders.
  • The largest Odonate Therapeutics, Inc. Common Stock buyer in Q2 2020 was BlackRock, an estimated $4.37M added.
  • The largest Odonate Therapeutics, Inc. Common Stock seller in Q2 2020 was Carillon Tower Advisers, an estimated $7.97M sold.

Based on aggregated 13F filings for Q2 2020.